Joyce S Plested Selected Research

NVX-CoV2373 adjuvated lipid nanoparticle

1/2022	Safety, immunogenicity, and efficacy of a COVID-19 vaccine (NVX-CoV2373) co-administered with seasonal influenza vaccines: an exploratory substudy of a randomised, observer-blinded, placebo-controlled, phase 3 trial.
1/2021	Efficacy of NVX-CoV2373 Covid-19 Vaccine against the B.1.351 Variant.
12/2020	Phase 1-2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Joyce S Plested Research Topics

Disease

4	COVID-19 01/2022 - 12/2020
4	Meningococcal Infections 12/2008 - 02/2002
2	Human Influenza (Influenza) 01/2022 - 01/2022
2	Bacteremia 06/2009 - 04/2003
1	Myalgia 01/2022
1	Fatigue 01/2022
1	Infections 01/2022
1	Pain (Aches) 01/2022
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2020
1	Hypoxia (Hypoxemia) 01/2020
1	Injection Site Reaction 01/2020

Drug/Important Bio-Agent (IBA)

8	VaccinesIBA 01/2022 - 02/2002
3	NVX-CoV2373 adjuvated lipid nanoparticleIBA 01/2022 - 12/2020
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2020
2	Immunoglobulin G (IgG)IBA 01/2022 - 12/2020
2	AntibodiesIBA 12/2008 - 01/2004
2	LipopolysaccharidesIBA 12/2008 - 04/2003
2	EpitopesIBA 12/2008 - 04/2003
1	VS 215IBA 01/2022
1	Saline SolutionIBA 01/2022
1	COVID-19 VaccinesIBA 01/2022
1	NanovaccinesIBA 01/2022
1	Influenza Vaccines (Influenza Vaccine)FDA Link 01/2022
1	Recombinant ProteinsIBA 06/2009
1	Immunodominant EpitopesIBA 02/2002

Therapy/Procedure

1	Contraindications 01/2022
1	Intramuscular Injections 01/2022